Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $46.15 USD
Change Today -1.05 / -2.22%
Volume 4.4M
GSK On Other Exchanges
Symbol
Exchange
OTC US
Xetra
Mexico
Frankfurt
As of 8:04 PM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - glaxosmithkline plc-spon adr (GSK)

Name (Connections)Board RelationshipsTitleKey Developments
Tom De Swaan 82 RelationshipsIndependent Non-Executive Director, Chairman of Remuneration Committee, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee, Member of Nominations Committee and Member of Finance CommitteeFair Trade Commission Fines Pfizer Inc., Merck Sharpe & Dohme, Eli Lilly & Co., Glaxosmithkline plc and Otsuka Group
01/15/09
Judy Lewent 85 RelationshipsIndependent Non-Executive Director, Chairman of Audit & Risk Committee, Member of Corporate Administration & Transactions Committee, Member of Finance Committee, Member of Remuneration Committee and Member of Nominations CommitteeGlaxoSmithKline plc Accepts $3 Billion Fine from US Regulators
07/3/12
Deryck Maughan 193 RelationshipsSenior Independent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee, Member of Nominations Committee, Member of Remuneration Committee and Member of Finance CommitteeGlaxoSmithKline plc Revise Earnings Results for the Year 2012 Due to IAS 19R Accounting Standards
02/6/13
Daniel Podolsky M.D. 40 RelationshipsIndependent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee, Member of Finance Committee and Member of Corporate Responsibility Committee 
Stacey Cartwright 15 RelationshipsIndependent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee and Member of Finance Committee 
Lynn Elsenhans 102 RelationshipsIndependent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee, Member of Finance Committee, Member of Corporate Responsibility Committee and Member of Nominations Committee 

Compensation Committee* - glaxosmithkline plc-spon adr (GSK)

Name (Connections)Board RelationshipsTitle
Stephanie Burns Ph.D. 101 RelationshipsIndependent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Remuneration Committee, Member of Finance Committee and Member of Corporate Responsibility Committee
Tom De Swaan 82 RelationshipsIndependent Non-Executive Director, Chairman of Remuneration Committee, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee, Member of Nominations Committee and Member of Finance Committee
Christopher Gent 115 RelationshipsNon-Executive Chairman, Chairman of Corporate Responsibility Committee, Member of Corporate Administration & Transactions Committee, Member of Nominations Committee, Member of Remuneration Committee and Member of Finance Committee
Judy Lewent 85 RelationshipsIndependent Non-Executive Director, Chairman of Audit & Risk Committee, Member of Corporate Administration & Transactions Committee, Member of Finance Committee, Member of Remuneration Committee and Member of Nominations Committee
Deryck Maughan 193 RelationshipsSenior Independent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee, Member of Nominations Committee, Member of Remuneration Committee and Member of Finance Committee
Urs Rohner 50 RelationshipsIndependent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Remuneration Committee and Member of Finance Committee
G. Wijers 67 RelationshipsIndependent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Remuneration Committee, Member of Finance Committee and Member of Corporate Responsibility Committee
GSK Compensation vs. Industry
1.1M
425.7K
Chief Executive Officer
718.0K
289.6K
Chief Financial Officer
Share price activity for GLAXOSMITHKLINE PLC-SPON ADR (GSK)
52 Week Price Performance
GSK
Industry Average

Nominating Committee* - glaxosmithkline plc-spon adr (GSK)

Name (Connections)Board RelationshipsTitleKey Developments
Christopher Gent 115 RelationshipsNon-Executive Chairman, Chairman of Corporate Responsibility Committee, Member of Corporate Administration & Transactions Committee, Member of Nominations Committee, Member of Remuneration Committee and Member of Finance CommitteeGlaxoSmithKline plc Announces Board Changes
02/26/15
Tom De Swaan 82 RelationshipsIndependent Non-Executive Director, Chairman of Remuneration Committee, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee, Member of Nominations Committee and Member of Finance CommitteeGlaxoSmithKline plc Announces Executive Changes
02/17/15
Judy Lewent 85 RelationshipsIndependent Non-Executive Director, Chairman of Audit & Risk Committee, Member of Corporate Administration & Transactions Committee, Member of Finance Committee, Member of Remuneration Committee and Member of Nominations CommitteeGlaxoSmithKline plc Announces Board Committee Changes
01/27/15
Philip Hampton MA, ACA, MBA 42 RelationshipsIndependent Non-Executive Director, Chairman of Nominations Committee, Member of Corporate Administration & Transactions Committee and Member of Finance CommitteeGlaxoSmithKline plc Confirms the Appointment of Moncef Slaoui as Chairman, Vaccines
10/22/14
Deryck Maughan 193 RelationshipsSenior Independent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee, Member of Nominations Committee, Member of Remuneration Committee and Member of Finance CommitteeBrian McNamara to Join GSK as Head of Americas and Europe for Consumer Health Businesses
10/10/14
Roy Anderson 15 RelationshipsIndependent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Finance Committee and Member of Nominations Committee
Lynn Elsenhans 102 RelationshipsIndependent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee, Member of Finance Committee, Member of Corporate Responsibility Committee and Member of Nominations Committee

Finance Committee* - glaxosmithkline plc-spon adr (GSK)

Name(Connections)Board RelationshipsTitle
Roy Anderson 15 RelationshipsIndependent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Finance Committee and Member of Nominations Committee
Stephanie Burns Ph.D. 101 RelationshipsIndependent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Remuneration Committee, Member of Finance Committee and Member of Corporate Responsibility Committee
Stacey Cartwright 15 RelationshipsIndependent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee and Member of Finance Committee
Tom De Swaan 82 RelationshipsIndependent Non-Executive Director, Chairman of Remuneration Committee, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee, Member of Nominations Committee and Member of Finance Committee
Simon Dingemans 16 RelationshipsChief Financial Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
Lynn Elsenhans 102 RelationshipsIndependent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee, Member of Finance Committee, Member of Corporate Responsibility Committee and Member of Nominations Committee
Christopher Gent 115 RelationshipsNon-Executive Chairman, Chairman of Corporate Responsibility Committee, Member of Corporate Administration & Transactions Committee, Member of Nominations Committee, Member of Remuneration Committee and Member of Finance Committee
Philip Hampton MA, ACA, MBA 42 RelationshipsIndependent Non-Executive Director, Chairman of Nominations Committee, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
Judy Lewent 85 RelationshipsIndependent Non-Executive Director, Chairman of Audit & Risk Committee, Member of Corporate Administration & Transactions Committee, Member of Finance Committee, Member of Remuneration Committee and Member of Nominations Committee
Deryck Maughan 193 RelationshipsSenior Independent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee, Member of Nominations Committee, Member of Remuneration Committee and Member of Finance Committee
Daniel Podolsky M.D. 40 RelationshipsIndependent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee, Member of Finance Committee and Member of Corporate Responsibility Committee
Urs Rohner 50 RelationshipsIndependent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Remuneration Committee and Member of Finance Committee
Moncef Slaoui Ph.D. 37 RelationshipsChairman of Global Vaccines, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
G. Wijers 67 RelationshipsIndependent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Remuneration Committee, Member of Finance Committee and Member of Corporate Responsibility Committee
Andrew Witty 15 RelationshipsChief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
Debt To Total Capitalization79.2x
It is important for the finance committee to know when to issue debt or equity.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:US $46.15 USD -1.05

GSK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
3M Co $164.95 USD -1.10
AbbVie Inc $58.54 USD +0.30
Actavis plc $297.62 USD -7.14
Amgen Inc $159.85 USD -4.45
Novo Nordisk A/S kr372.00 DKK -4.80
View Industry Companies
 

Industry Analysis

GSK

Industry Average

Valuation GSK Industry Range
Price/Earnings 26.6x
Price/Sales 3.1x
Price/Book 17.0x
Price/Cash Flow 26.6x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC-SPON ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.